SCHEMBL7019299

SCHEMBL7019299

C#Cc1cccc(Nc2ncnc3[nH]cc(I)c23)c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 12/20 0.51
GAK O14976 3/20 0.51
FBP1 P09467 2/20 0.51
ALDH1A1 P00352 1/20 0.51
MAPT P10636 1/20 0.51
KDR P35968 2/20 0.49
AURKA O14965 2/20 0.49
RPS6KB1 P23443 1/20 0.49
RIPK2 O43353 2/20 0.47
BUB1 O43683 2/20 0.47
STK10 O94804 2/20 0.47
MAP3K1 Q13233 2/20 0.47
PIP4K2C Q8TBX8 2/20 0.47
SLK Q9H2G2 2/20 0.47
CARS1 P49589 1/20 0.47
DYRK1A Q13627 1/20 0.47
DYRK1B Q9Y463 1/20 0.47
BRAF P15056 4/20 0.47
TNNI3K Q59H18 4/20 0.47
ERBB2 P04626 2/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7016150 0.86 BRAF (0.58) EGFRGAKFBP1ALDH1A1MAPT
SCHEMBL3535063 0.85 BRAF (0.59) EGFRGAKFBP1ALDH1A1MAPT
SCHEMBL7022596 0.85 BRAF (0.60) EGFRGAKFBP1ALDH1A1MAPT
Hydrochloric Acid SCHEMBL7017702 0.84 BRAF (0.59) EGFRGAKFBP1ALDH1A1MAPT
SCHEMBL7024286 0.83 EGFR (0.53) EGFRGAKFBP1ALDH1A1MAPT
SCHEMBL7016715 0.82 EGFR (0.48) EGFRGAKFBP1ALDH1A1MAPT
SCHEMBL7025011 0.81 AURKA (0.56) EGFRGAKFBP1ALDH1A1MAPT
SCHEMBL7019463 0.81 EGFR (0.61) EGFRKDRBRAFTNNI3KERBB2
SCHEMBL7661400 0.81 BRAF (0.50) EGFRGAKFBP1ALDH1A1MAPT
SCHEMBL7663774 0.80 BRAF (0.53) EGFRGAKFBP1ALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0831829-B1 HETEROCYCLIC RING-FUSED PYRIMIDINE DERIVATIVES PFIZER (US) 2003-08-20 EP claimed
JP-3290666-B2 2002-06-10 JP claimed
US-6395733-B1 ANTICANCER AGENTS; ANTIPROLIFERATIVE AGENTS PFIZER INC 2002-05-28 US claimed
EP-0831829-A4 HETEROCYCLIC RING-FUSED PYRIMIDINE DERIVATIVES PFIZER (US) 1998-11-25 EP claimed
EP-0831829-A1 HETEROCYCLIC RING-FUSED PYRIMIDINE DERIVATIVES PFIZER INC. (US) 1998-04-01 EP claimed
CN-1141298-A Pyrimidine-fused heterocyclic compound anti-cancer agents PFIZER (US) 1997-01-29 CN claimed
WO-1996040142-A1 HETEROCYCLIC RING-FUSED PYRIMIDINE DERIVATIVES PFIZER INC. (US) 1996-12-19 WO claimed
EP-0831829-B1 HETEROCYCLIC RING-FUSED PYRIMIDINE DERIVATIVES PFIZER (US) 2003-08-20 EP disclosed
US-6395733-B1 ANTICANCER AGENTS; ANTIPROLIFERATIVE AGENTS PFIZER INC 2002-05-28 US disclosed
EP-0831829-A4 HETEROCYCLIC RING-FUSED PYRIMIDINE DERIVATIVES PFIZER (US) 1998-11-25 EP disclosed
EP-0831829-A1 HETEROCYCLIC RING-FUSED PYRIMIDINE DERIVATIVES PFIZER INC. (US) 1998-04-01 EP disclosed
CN-1141298-A Pyrimidine-fused heterocyclic compound anti-cancer agents PFIZER (US) 1997-01-29 CN disclosed
WO-1996040142-A1 HETEROCYCLIC RING-FUSED PYRIMIDINE DERIVATIVES PFIZER INC. (US) 1996-12-19 WO disclosed